AXIM Biotechnologies has selected the coastal city of Almere in the Netherlands, for its future hemp-based products manufacturing facility headquarters.

The company, which is focused on research, development and production of pharmaceutical, nutraceutical and cosmetic products, has executed an option agreement for a land purchase of a 5,328m² industrial land.

Currently, the company also holds a design and feasibility services agreement with a Dutch commercial real-estate developer G&S Bouw.

The new office building will feature a clean laboratory zone, storage areas, office and technical rooms as well as manufacturing facility furnishings.

Project design and feasibility has already been initiated, while the construction is scheduled to be completed by 2017.

AXIM Biotechnologies chief executive officer Dr George Anastassov said: “Here at AXIM, we are delighted to initiate the acquisition of a land parcel at the city of Almere at The Netherlands. [Read More]